---
title: "Solstad Maritime to webcast Q2 2026 results presentation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292025126.md"
description: "Solstad Maritime will webcast its Q2 2026 results presentation on July 15, 2026, at 09:00 CEST. The results presentation is scheduled for release at 07:00 CEST on the same day."
datetime: "2026-07-08T07:00:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292025126.md)
  - [en](https://longbridge.com/en/news/292025126.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292025126.md)
generator: "portal-rs"
---

# Solstad Maritime to webcast Q2 2026 results presentation

-   Solstad Maritime schedules a live webcast for its Q2 2026 results on July 15, 2026, at 09:00 CEST. \* Results presentation set for release at 07:00 CEST on July 15, 2026 via here and here. \* Webcast access: here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solstad Maritime ASA published the original content used to generate this news brief via Cision (Ref. ID: 20260707:BIT:6439:0) on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

## Related News & Research

- [Itera ASA to present preliminary Q2 2026 results via webcast](https://longbridge.com/en/news/296590225.md)
- [Eolus schedules webcast, teleconference to present Q2 interim report](https://longbridge.com/en/news/296458713.md)
- [Proximar Seafood to webcast H1 and Q2 2026 results presentation](https://longbridge.com/en/news/296573501.md)
- [Lytix Biopharma to webcast Q2 2026 results presentation](https://longbridge.com/en/news/296571638.md)
- [HAV Group schedules Q2 2026 results webcast presentation](https://longbridge.com/en/news/296448086.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**